1-3 of 3
Hongbo Yu, MD
Close
Sort by
Journal Articles

Resolving the Biological Heterogeneity of B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between DLBCL and BL (BCL-U) Using Quantitative Profiles of Oncogenic Signaling Networks

Christopher Daniel Carey, MD,, Daniel Gusenleitner, MS, Zhang Xuan, BA, Aliyah R Sohani, MD, Olga Weinberg, MD, Hongbo Yu, MD, Ben Chen, MD PhD, Bruce Woda, MD, Kai Fu, MD PhD, Stefano Monti, PhD, Scott J. Rodig, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 3903.
https://doi.org/10.1182/blood.V126.23.3903.3903
Published: 2015
Journal Articles

SYK and STAT3 Are Active in Diffuse Large B-Cell Lymphoma: Activity of Cerdulatinib, a Dual SYK/JAK Inhibitor

Y. Lynn Wang, MD PhD, Jiao Ma, PhD, Wei Xing, PhD, Pin Lu, MD PhD, Karen Dresser, Ailin Guo, PhDMD, Anjali Pandey, PhD, Pamela B. Conley, PhD, Hongbo Yu, MD PhD, Greg Coffey, PhD
Journal: Blood
Blood (2014) 124 (21): 926.
https://doi.org/10.1182/blood.V124.21.926.926
Published: 2014
Journal Articles

Expression of CD25 on Acute Myeloid Leukemia (AML) Blasts Is An Independent Risk Factor Associated with Refractory Disease, Which May Be Overcome by Stem Cell Transplantation (SCT),

Jan Cerny, MD, PhD, Lesley Woods, MD, Hongbo Yu, MD, PhD, Muthalagu Ramanathan, MD, Glen D Raffel, M.D, Ph.D., William V Walsh, MD, Laura J Petrillo-Deluca, PA-C, Natasha M Tarrasky, PA-C, Elizabeth O'Rourke, NP, Jayde L Bednarik, PharmD, Bruce Woda, MD, Lloyd Hutchinson, PhD, Aimee Kroll, MS, Bruce Barton, PhD, Alan G. Rosmarin, MD, Rajneesh Nath, MD
Journal: Blood
Blood (2011) 118 (21): 3560.
https://doi.org/10.1182/blood.V118.21.3560.3560
Published: 2011